Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT01291719

Insulin Balanced Infusion System

Insulin Balanced Infusion System Control of Glucose

Status
Active Not Recruiting
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Admetsys Corporation · Industry
Sex
All
Age
21 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to study the use of a counterbalancing system of glucose and insulin infusion with frequent blood glucose monitoring and combined adaptive algorithm can produce tight glycemic control without hypoglycemia; study to develop a closed loop for use in intensive care units and surgery

Detailed description

The study is using an experimental design outpatient with individuals having treatment using an automated closed loop glucose control unit; glucoses are measured every 5 minutes using a intravenous glucose sensor and infusion of glucose and insulin are altered without manual intervention as directed by algorithm

Conditions

Interventions

TypeNameDescription
DEVICEglucose and insulin infusionscombined algorithm directed glucose and insulin infusion with 5 minute blood glucose measurements to direct glucose control; regular insulin and glucose are infused intravenously as adjusted by the algorithm without manual intervention in the group of diabetic individuals under study to adjust the glucose level to a target range of 80-180 mg/dl

Timeline

Start date
2008-11-01
Primary completion
2026-11-01
Completion
2026-11-01
First posted
2011-02-08
Last updated
2024-07-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01291719. Inclusion in this directory is not an endorsement.

Insulin Balanced Infusion System (NCT01291719) · Clinical Trials Directory